Arkolith/Insider Trading/BEAM/Form 4

Simon Amy

Chief Medical OfficerBeam Therapeutics Inc. (BEAM) · full profile →Form 4 · filed Apr 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$548K
Net Open-Market Flow
-$548K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 2, 2025Sell(S)21K$17.73$372K66K
Apr 1, 2025Sell(S)10K$18.35$176K87K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-050852) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML